Randall E. Stauffer Appointed to QNB Bank Board of Directors Effective January 1, 2026 GlobeNewswire December 30, 2025 Quakertown, PA, Dec. 30, 2025 (GLOBE NEWSWIRE) — QNB Bank, a subsidiary of QNB Corp. (OTCQX: QNBC), is pleased to announce that Randall E. Stauffer has been appointed to the Board of Directors, as a Class II […]
United States Mint Acting Director McNally to Participate in the 71st Annual Florida United Numismatists Convention in Orlando GlobeNewswire December 30, 2025 WASHINGTON, D.C., Dec. 30, 2025 (GLOBE NEWSWIRE) — United States Mint (Mint) Acting Director Kristie McNally will participate in the ribbon cutting opening ceremony of the 71st Annual Florida United Numismatists (FUN) Convention
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Graphic Packaging Holding Company – GPK GlobeNewswire December 30, 2025 NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company (“Graphic Packaging” or the “Company”) (NYSE: GPK). Such investors are advised
Overture Orthopaedics, a privately held U.S.-based medical device company providing surgeons with innovative joint preservation solutions in sports medicine and orthopaedic surgery, announced it has achieved the $1.0M milestone in sales of its award-winning OvertureTi Knee Resurfacing System. https://mma.prnewswire.com/media/2852958/Overture_Implants.jpg OvertureTi Knee Resurfacing System implants are designed specifically as an alternative when it is still too
(NASDAQ:FRMI), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fermi and certain of its officers and/or directors have engaged
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fermi Inc. – FRMI GlobeNewswire December 30, 2025 NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI). Such investors are advised to contact Danielle Peyton at
(NYSE:ADCT), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ADC Therapeutics and certain of its officers and/or
(NASDAQ:SNDL), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. (“SNDL” or the “Company”) (NASDAQ: SNDL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SNDL and certain of its officers and/or directors have engaged
(NYSE:APD), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Air Products and Chemicals, Inc. (“Air Products” or the “Company”) (NYSE: APD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Air Products and certain of its
(NASDAQ:AVAV), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. (“Aerovironment” or the “Company”) (NASDAQ: AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aerovironment and certain of its officers and/or directors have engaged